John A. McCoy Jr.

Insider · Vice President and Controller · ABT

John A. McCoy Jr. files insider transactions with the SEC as a vice president and controller of Abbott Laboratories (ABT). We hold 2 disclosed purchases and sales filed since 6 July 2015, 1 of them in the last 90 days.

Files forABT
Disclosed buys and sells2 in all, 1 in the last 90 days
Last disclosure3 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 1 September 2023 — 2 September 2026Vice President and Controller · Abbott Laboratories (ABT)23 Form 4 lines · source: SEC Form 4
Filed 1 July 2015 — 3 June 2016SVP and Controller · Baxalta (BXLT)25 Form 4 lines · source: SEC Form 4

Everything they disclosed

48 entries, newest first — one per disclosure report, one per Form 4 line

had shares withheld for tax on 52 shares of Abbott LaboratoriesSEC Form 43 September 2026Common shares without par value · traded 1 September 2026 · filed 3 September 2026
▼ sold on the open market 27 shares of Abbott LaboratoriesSEC Form 43 September 2026Common shares without par value · traded 2 September 2026 · filed 3 September 2026
had shares withheld for tax on 1,142 shares of Abbott LaboratoriesSEC Form 43 March 2026Common shares without par value · traded 27 February 2026 · filed 3 March 2026
▼ sold on the open market 585 shares of Abbott LaboratoriesSEC Form 43 March 2026Common shares without par value · traded 2 March 2026 · filed 3 March 2026
had shares withheld for tax on 1,142 shares of Abbott LaboratoriesSEC Form 43 March 2026Common shares without par value · traded 27 February 2026 · filed 3 March 2026
▼ sold on the open market 585 shares of Abbott LaboratoriesSEC Form 43 March 2026Common shares without par value · traded 2 March 2026 · filed 3 March 2026
was granted 5,373 shares of Abbott LaboratoriesSEC Form 426 February 2026Common shares without par value · traded 24 February 2026 · filed 26 February 2026
was granted 22,151 shares of Abbott Laboratories (a derivative holding)SEC Form 426 February 2026Option (right to buy) · traded 24 February 2026 · filed 26 February 2026
was granted 22,151 shares of Abbott Laboratories (a derivative holding)SEC Form 426 February 2026Option (right to buy) · traded 24 February 2026 · filed 26 February 2026
was granted 5,373 shares of Abbott LaboratoriesSEC Form 426 February 2026Common shares without par value · traded 24 February 2026 · filed 26 February 2026
had shares withheld for tax on 79 shares of Abbott LaboratoriesSEC Form 43 September 2025Common shares without par value · traded 1 September 2025 · filed 3 September 2025
had shares withheld for tax on 1,096 shares of Abbott LaboratoriesSEC Form 44 March 2025Common shares without par value · traded 28 February 2025 · filed 4 March 2025
▼ sold on the open market 562 shares of Abbott LaboratoriesSEC Form 44 March 2025Common shares without par value · traded 3 March 2025 · filed 4 March 2025
was granted 15,040 shares of Abbott Laboratories (a derivative holding)SEC Form 427 February 2025Option (right to buy) · traded 25 February 2025 · filed 27 February 2025
was granted 4,038 shares of Abbott LaboratoriesSEC Form 427 February 2025Common shares without par value · traded 25 February 2025 · filed 27 February 2025
had shares withheld for tax on 52 shares of Abbott LaboratoriesSEC Form 44 September 2024Common shares without par value · traded 1 September 2024 · filed 4 September 2024
▼ sold on the open market 27 shares of Abbott LaboratoriesSEC Form 44 September 2024Common shares without par value · traded 4 September 2024 · filed 4 September 2024
had shares withheld for tax on 921 shares of Abbott LaboratoriesSEC Form 44 March 2024Common shares without par value · traded 29 February 2024 · filed 4 March 2024
▼ sold on the open market 472 shares of Abbott LaboratoriesSEC Form 44 March 2024Common shares without par value · traded 1 March 2024 · filed 4 March 2024
was granted 16,563 shares of Abbott Laboratories (a derivative holding)SEC Form 423 February 2024Option (right to buy) · traded 21 February 2024 · filed 23 February 2024
was granted 4,407 shares of Abbott LaboratoriesSEC Form 423 February 2024Common shares without par value · traded 21 February 2024 · filed 23 February 2024
was granted 2,071 shares of Abbott Laboratories (a derivative holding)SEC Form 46 September 2023Option (right to buy) · traded 1 September 2023 · filed 6 September 2023
was granted 531 shares of Abbott LaboratoriesSEC Form 46 September 2023Common shares without par value · traded 1 September 2023 · filed 6 September 2023
was granted 854 shares of BaxaltaSEC Form 47 June 2016Common Stock, par value $0.01 per share · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 24,909 shares of BaxaltaSEC Form 47 June 2016Common Stock, par value $0.01 per share · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 1,887 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 8,327 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 9,292 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 25,459 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 11,137 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
returned to the issuer 63,406 shares of Baxalta (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
had shares withheld for tax on 84 shares of BaxaltaSEC Form 48 March 2016Common Stock, par value $0.01 per share · traded 7 March 2016 · filed 8 March 2016
was granted 10,173 shares of BaxaltaSEC Form 47 March 2016Common Stock, par value $0.01 per share · traded 3 March 2016 · filed 7 March 2016
had shares withheld for tax on 410 shares of BaxaltaSEC Form 47 March 2016Common Stock, par value $0.01 per share · traded 3 March 2016 · filed 7 March 2016
had shares withheld for tax on 88 shares of BaxaltaSEC Form 47 March 2016Common Stock, par value $0.01 per share · traded 4 March 2016 · filed 7 March 2016
was granted 178 shares of BaxaltaSEC Form 417 February 2016Common Stock, par value $0.01 per share · traded 15 February 2016 · filed 17 February 2016
had shares withheld for tax on 208 shares of BaxaltaSEC Form 417 February 2016Common Stock, par value $0.01 per share · traded 15 February 2016 · filed 17 February 2016
was granted 151 shares of BaxaltaSEC Form 417 February 2016Common Stock, par value $0.01 per share · traded 15 February 2016 · filed 17 February 2016
was granted 63,406 shares of Baxalta (a derivative holding)SEC Form 43 December 2015Stock Option (Right to Buy) · traded 1 December 2015 · filed 3 December 2015
was granted 44 shares of BaxaltaSEC Form 413 August 2015Common Stock, par value $0.01 per share · traded 11 August 2015 · filed 13 August 2015
was granted 47 shares of BaxaltaSEC Form 413 August 2015Common Stock, par value $0.01 per share · traded 11 August 2015 · filed 13 August 2015
acquired or disposed of, other 2,999 shares of BaxaltaSEC Form 46 July 2015Common Stock, par value $0.01 per share · traded 1 July 2015 · filed 6 July 2015
acquired or disposed of, other 11,158 shares of BaxaltaSEC Form 46 July 2015Common Stock, par value $0.01 per share · traded 1 July 2015 · filed 6 July 2015
acquired or disposed of, other 1,887 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015
acquired or disposed of, other 8,327 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015
acquired or disposed of, other 9,292 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015
acquired or disposed of, other 25,459 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015
was granted 11,137 shares of Baxalta (a derivative holding)SEC Form 46 July 2015Stock Option (Right to Buy) · traded 1 July 2015 · filed 6 July 2015

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.